首页|津力达颗粒联合司美格鲁肽对肥胖非酒精性脂肪肝保护作用研究

津力达颗粒联合司美格鲁肽对肥胖非酒精性脂肪肝保护作用研究

扫码查看
目的 探讨津力达颗粒联合司美格鲁肽对肥胖非酒精性脂肪肝(NAFLD)小鼠的保护作用.方法 选取6 周龄C57BL/6J雄性小鼠32 只,随机取8 只作为正常组(普通饲料喂养),其余小鼠给予高脂肪饲料喂养 12 周建立 NAFLD 模型.将造模成功的 NAFLD 小鼠随机分为NAFLD组、司美格鲁肽组、津力达联合司美格鲁肽组,每组8 只.司美格鲁肽组给予司美格鲁肽30 nmol/kg腹腔内注射,津力达联合司美格鲁肽组在注射司美格鲁肽基础上给予津力达颗粒1.5 g/kg灌胃,正常组和NAFLD组给予生理盐水灌胃,均1 次/d,连续干预12 周.记录各组小鼠的体重,检测血脂指标[三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)]、肝功能指标[丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)]和空腹胰岛素(FINS)水平,HE染色、油红O染色、Masson染色和透射电镜观察肝脏组织病理学变化.结果 NAFLD组小鼠体重及血清ALT、AST、TG、TC、LDL-C水平均明显高于正常组(P均<0.05);肝组织中可见大面积弥漫性肝细胞脂肪变性、肝细胞气球样变和淋巴细胞局灶性浸润,大量脂质沉积,线粒体肿胀,线粒体嵴断裂、减少,可见线粒体微自噬结构.与NAFLD组比较,司美格鲁肽组、津力达联合司美格鲁肽组小鼠体重及血清ALT、AST、TG、TC、LDL-C、FINS水平均明显降低(P均<0.05),肝组织病变明显减轻;与司美格鲁肽组比较,津力达联合司美格鲁肽组上述各指标更低(P均<0.05),肝组织病变更轻.结论 津力达颗粒联合司美格鲁肽可明显调节NAFLD小鼠脂代谢,保护肝功能,减轻胰岛素抵抗,改善肝脏脂肪变性、脂质沉积、炎细胞浸润和线粒体微自噬结构.
Protective effect of Jinlida granule combined with semaglutide on non-alcoholic fatty liver disease
Objective It is to explore the protective effect of Jinlida granule combined with semaglutide on obese mice with non-alcoholic fatty liver disease(NAFLD).Methods Thirty-two 6-week-old C57BL/6J male mice were selected,in which 8 mince were randomly selected as normal group fed with normal diet,and the other mice were fed with high-fat diet for 12 weeks to establish NAFLD models.The successfully modeled NAFLD mice were randomly divided into NAFLD group,semaglutide group,Jinlida combined with semiglutide group(combination group),with 8 mice in each group.The semaglutide group was given semiglutide 30 nmol/kg by intraperitoneal injection,the combination group was given Jinlida granules 1.5 g/kg by gavage on the basis of semaglutide by injection,the normal group and NAFLD group were given nor-mal saline by gavage,all once daily,continuously treated for 12 weeks.The body weight of mice in each group was recor-ded,and the levels of blood lipids[triacylglycerol(TG),total cholesterol(TC),high density lipoprotein cholesterol(HDL-C),low density lipoprotein cholesterol(LDL-C)],liver function indexes[alanine aminotransferase(ALT),aspar-tate aminotransferase(AST)]and fasting insulin(FINS)were detected.The histopathological changes of liver were ob-served by HE staining,oil red O staining,Masson staining and transmission electron microscopy.Results The body weight and serum levels of ALT,AST,TG,TC and LDL-C in the NAFLD group were significantly higher than those in the normal group(all P<0.05).Extensive diffuse hepatocyte steatosis,hepatocyte balloon-like degeneration,focal lymphocyte infil-tration,large amount of lipid deposition,mitochondrial swelling,mitochondrial ridge breakage and reduction,and mito-chondrial microautophagy were observed in the liver tissue.Compared with the NAFLD group,the body weight and serum levels of ALT,AST,TG,TC,LDL-C and FINS of mice in the semaglutide group and combination group were significantly decreased(all P<0.05),and the liver lesions were significantly alleviated.Compared with the semaglutide group,the de-creases of the above indexes were more significant in the combination group(all P<0.05),and the liver lesions were more milder.Conclusion Jinlida granules combined with semaglutide can significantly regulate lipid metabolism,protect liver function,alleviate insulin resistance,improve liver steatosis,lipid deposition,inflammatory cell infiltration and mitochon-drial microautophagy structure in NAFLD mice.

non-alcoholic fatty liver diseaseobesityJinlida granulessemaglutidemitochondrion

牛姝、王晨曦、吴笛、孙政、陈杏

展开 >

石家庄市人民医院,河北 石家庄 050011

河北医科大学,河北 石家庄 050000

石家庄市中医院,河北 石家庄 050000

河北省人民医院,河北 石家庄 050000

展开 >

非酒精性脂肪肝 肥胖 津力达颗粒 司美格鲁肽 线粒体

河北省中医药管理局科研计划项目

2024127

2024

现代中西医结合杂志
中国中西医结合学会河北分会,中华中医药学会

现代中西医结合杂志

CSTPCD
影响因子:1.775
ISSN:1008-8849
年,卷(期):2024.33(16)